Researchers analyzed data from 718 patients with severe acute respiratory distress syndrome (ARDS) who required extracorporeal membrane oxygenation (ECMO). The study looked at how the amount of time spent on noninvasive respiratory support before starting ECMO related to patient survival.
The analysis found that survivors spent significantly fewer days on noninvasive respiratory support before starting ECMO. Specifically, survivors spent about 1.88 fewer days on this support compared to those who did not survive. Survivors also had a significantly shorter total duration of all pre-ECMO respiratory support, which included both noninvasive and invasive methods.
Because this study is based on observational data, it shows a link rather than a direct cause. The evidence for these findings is considered low to very low certainty. These results are intended to help generate new ideas for treatment timing. Patients and doctors should discuss these findings with a medical team to understand how they apply to specific cases.
Common questions
What did the study find about noninvasive respiratory support?
The study found that patients who survived had a significantly shorter duration of noninvasive respiratory support before starting ECMO. Specifically, survivors spent 1.88 fewer days on noninvasive support than those who did not survive. This suggests that a shorter duration of this support may be linked to better outcomes for patients with severe respiratory distress.
How much shorter was the total respiratory support for survivors?
Survivors had a significantly shorter total duration of pre-ECM respiratory support, which includes both noninvasive and invasive methods. The data showed that survivors spent 3.49 fewer days on total respiratory support before starting ECMO compared to non-survivors.
Is this finding a proven treatment for ARDS?
The study is based on observational data and is considered hypothesis-generating, meaning it shows a link but does not prove that one thing caused another. Because the evidence is of low to very low certainty, these results are not yet used to change standard medical practice. Patients should consult their doctors regarding specific treatment plans.
